These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2010-019464-37 effects of dynamic co2 therapy in periodic breathing in heart failure patients Effetti della somministrazione dinamica di anidride carbonica nella sindrome delle apnee centrali in pazienti con scom... not-yet-due
Ongoing 2010-024485-21 Dipyridamole versus Adenosine infusion in the physiologic assessment of Intermediate coronary Stenoses in the cardiac catheterization laboratorY Infusione di dipiridamolo contro adenosina nella val... not-yet-due
Ongoing 2013-000759-41 A prospective, open-label, single center, cross-over, controlled, randomized, phase III study to test superiority of the oral solution of synthetic thyroxine compared to tablet preparation for treat... not-yet-due
Completed, but no date, and reported results 2015-005383-42 Use of buspiron in chemioreflex modulation and central apnea treatment in heart failure patients (BREATH: BuspiRon for chEmoreflex modulation and central Apnea treatment in Heart failure patients). Ph... bad-data
Completed, but no date, and reported results 2015-005384-16 A prospective single-arm, monocentric, phase-II explorative study on evaluation of diagnostic use of the PET tracer (18F)-florbetaben (Neuraceq®) in patient with patient with suspected cardiac amyloid... bad-data
Completed, but no date, and reported results 2017-001660-38 A prospective triple-arm, monocentric, phase-II explorative study on evaluation of diagnostic efficacy of the PET tracer (18F)-florbetaben (Neuraceq®) in patients with cardiac amyloidosis - FLORAMICAR... bad-data
Ongoing, reported early 2018-000832-82 GLYcemic Control with EMpagliflozin vs standard of care in patients with type 2 dIAbetes and Heart failure: effects on cardiac remodeling and neurohormonal activation EFFETTI DI EMPAGLIFLOZIN SU RI... not-yet-due
Ongoing 2021-000730-34 HeAd-to-head compaRison of single versus dual antiplatelet treatMent strategY after percutaneous left atrial appenDAge closure: A MULticenter, randomizEd sTudy the ARMYDA-AMULET study Confronto tr... not-yet-due
Completed, but no date Terminated 2021-001564-26 Evaluation of the cardioprotective metabolic effect of trimetazidine in patients with myocardial ischaemia Valutazione dell’effetto metabolico cardioprotettivo della Trimetazidina in pazienti con i... bad-data
Ongoing 2022-000686-40 Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis Studio prospettic... not-yet-due
Ongoing 2022-002585-33 A multi-center phase 3 study of 18F-florbetaben positron emission tomography/computed tomography (PET-CT) Studio multicentrico di fase 3 sulla diagnosi non invasiva di amiloidosi cardiaca da catene... not-yet-due